TNF and Cachexia: TNF-like weak inducer of apoptosis (TWEAK), with its cognate receptor FN14 have also been implicated in muscle wasting and have been considered candidate targets for therapeutic intervention [140], although drugs targeting TNF-α have had limited success in cachexia human trials [141].